Haematologica (Jul 2019)

Molecular mechanisms of bleeding disorderassociated GFI1BQ287* mutation and its affected pathways in megakaryocytes and platelets

  • Rinske van Oorschot,
  • Marten Hansen,
  • Johanna M. Koornneef,
  • Anna E. Marneth,
  • Saskia M. Bergevoet,
  • Maaike G.J.M. van Bergen,
  • Floris P.J. van Alphen,
  • Carmen van der Zwaan,
  • Joost H.A. Martens,
  • Michiel Vermeulen,
  • Pascal W.T.C. Jansen,
  • Marijke P.A. Baltissen,
  • Britta A.P. Laros-van Gorkom,
  • Hans Janssen,
  • Joop H. Jansen,
  • Marieke von Lindern,
  • Alexander B. Meijer,
  • Emile van den Akker,
  • Bert A. van der Reijden

DOI
https://doi.org/10.3324/haematol.2018.194555
Journal volume & issue
Vol. 104, no. 7

Abstract

Read online

Dominant-negative mutations in the transcription factor Growth Factor Independence-1B (GFI1B), such as GFI1BQ287*, cause a bleeding disorder characterized by a plethora of megakaryocyte and platelet abnormalities. The deregulated molecular mechanisms and pathways are unknown. Here we show that both normal and Q287* mutant GFI1B interacted most strongly with the lysine specific demethylase-1 – REST corepressor - histone deacetylase (LSD1-RCOR-HDAC) complex in megakaryoblasts. Sequestration of this complex by GFI1BQ287* and chemical separation of GFI1B from LSD1 induced abnormalities in normal megakaryocytes comparable to those seen in patients. Megakaryocytes derived from GFI1BQ287*-induced pluripotent stem cells also phenocopied abnormalities seen in patients. Proteome studies on normal and mutant-induced pluripotent stem cell-derived megakaryocytes identified a multitude of deregulated pathways downstream of GFI1BQ287* including cell division and interferon signaling. Proteome studies on platelets from GFI1BQ287* patients showed reduced expression of proteins implicated in platelet function, and elevated expression of proteins normally downregulated during megakaryocyte differentiation. Thus, GFI1B and LSD1 regulate a broad developmental program during megakaryopoiesis, and GFI1BQ287* deregulates this program through LSD1-RCOR-HDAC sequestering.